TabacaleraYsidron Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
TabacaleraYsidron General Information
Description
Mount TAM Biotechnologies Inc is a biopharmaceutical company operating in the US. Its core business is to optimize, develop a portfolio of products focused on improving the health and wellbeing of individuals afflicted with serious diseases, with a key product targeting systemic lupus erythematosus (SLE) and a strategy to bring to market novel therapeutics across a range of serious disease areas. The company mainly focuses on the development of a product candidate in the field of SLE, an autoimmune disorder where treatments are inadequate to control disease and a condition where serious unmet need remains. It product candidates is TAM-01 and TAM-03 which are novel rapalogs in action of binding and inhibition of the mammalian Target of Rapamycin.
Contact Information
- 100 Europa Drive
- Suite 455
- Chapel Hill, NC 27517
- United States
TabacaleraYsidron Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TabacaleraYsidron Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mount Tam Biotechnologies | 14-Aug-2015 | 0000000 00 | Pharmaceuticals |